Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00374686 · ClinicalTrials.gov registry record · NA
Study of Prophylactic Vs Preemptive Valganciclovir
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT00374686 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 120 participants.
The verdict
NCT00374686, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
This is a study of prophylactic Vs preemptive oral valganciclovir for management of cytomegalovirus infection in adult renal transplant recipients looking at clinical and pharmacoeconomic outcomes
Interventions
- DRUG Valganciclovir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2003-03 |
| Est. Completion | 2005-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00374686
The ClinicalTrials.gov registry entry for NCT00374686 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Valganciclovir is the first listed.
NCT00374686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00374686 about?
NCT00374686 is a clinical study titled "Study of Prophylactic Vs Preemptive Valganciclovir". This is a study of prophylactic Vs preemptive oral valganciclovir for management of cytomegalovirus infection in adult renal transplant recipients looking at clinical and pharmacoeconomic outcomes
What is the current status of trial NCT00374686?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2003-03. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00374686?
The interventions under investigation include: Valganciclovir (DRUG).
Who is sponsoring clinical trial NCT00374686?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.